NEW YORK (GenomeWeb) ― In the first update since 2007, the US Preventative Services Task Force recently provided new guidelines to clinicians for chlamydia and gonorrhea screening. These follow an update on recommendations for laboratory detection of the pathogens issued earlier this year by the US Centers for Disease Control and Prevention.
While the new USPSTF guidelines are essentially the same with respect to patient populations, both new updates strongly emphasize the benefits of commercially available nucleic acid amplification tests.